ClinVar Miner

Submissions for variant NM_000257.4(MYH7):c.2578A>G (p.Lys860Glu)

gnomAD frequency: 0.00001  dbSNP: rs759225115
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 3
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Agnes Ginges Centre for Molecular Cardiology, Centenary Institute RCV000172891 SCV000223882 uncertain significance Hypertrophic cardiomyopathy 1 2015-02-25 criteria provided, single submitter research This MYH7 Lys860Glu is a novel finding. To our knowledge, no other variant which results in an amino acid substitution at this location has been observed in either controls or HCM cases. This variant is absent in large population databases including the 1000 genomes project (http://www.1000genomes.org/), and the Exome Aggregation Consortium dataset (http://exac.broadinstitute.org/), suggesting that an amino acid substitution at this site may not be tolerated. We have identified the MYH7 Lys860Glu variant in 1 individual out of >200 index HCM cases who have been genetically screened. Furthermore, this variant is not detected in >160 in-house exomes of unrelated individuals with diverse cardiac phenotypes. Computational tools predict the MYH7 Lys860Glu variant to be "deleterious" (SIFT) and "disease-causing" (MutationTaster). Additionally, a tool specifically designed to predict the effects of missense variants in HCM genes (Jordan DM, et al., 2011), predicts that this variant is causative of the disease. No other informative relatives were identified in this family for segregation analysis. Based on the absence of this variant in the general population, and predictions from a number of in silico models, we suspect this variant to possibly be disease-causing. At this time however, we do not have sufficient evidence to support its role in disease. Thus, we classify this MYH7 Lys860Glu variant as one of "uncertain significance".
Invitae RCV001852103 SCV002135877 uncertain significance Hypertrophic cardiomyopathy 2021-11-06 criteria provided, single submitter clinical testing This variant is found within a region of MYH7 between codons 181 and 937 that contains the majority of the myosin head domain. Missense variants in this region have been shown to be significantly overrepresented in individuals with hypertrophic cardiomyopathy (PMID: 27532257). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be disruptive. ClinVar contains an entry for this variant (Variation ID: 192312). This missense change has been observed in individual(s) with hypertrophic cardiomyopathy (PMID: 28790153, 32894683). This variant is not present in population databases (gnomAD no frequency). This sequence change replaces lysine, which is basic and polar, with glutamic acid, which is acidic and polar, at codon 860 of the MYH7 protein (p.Lys860Glu).
Ambry Genetics RCV002453603 SCV002739581 uncertain significance Cardiovascular phenotype 2021-11-03 criteria provided, single submitter clinical testing The p.K860E variant (also known as c.2578A>G), located in coding exon 20 of the MYH7 gene, results from an A to G substitution at nucleotide position 2578. The lysine at codon 860 is replaced by glutamic acid, an amino acid with similar properties. This alteration is located in the myosin head domain, which contains a statistically significant clustering of pathogenic missense variants (Homburger JR et al. Proc Natl Acad Sci U S A, 2016 06;113:6701-6; Walsh R et al. Genet Med, 2017 02;19:192-203; Ambry internal data). This variant has been reported in at least two individuals with hypertrophic cardiomyopathy (HCM); however, clinical details were limited (Ambry internal data; Burns C et al. Circ Cardiovasc Genet, 2017 Aug;10:[Epub ahead of print]). This amino acid position is well conserved in available vertebrate species. In addition, the in silico prediction for this alteration is inconclusive. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.